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Abstract
Oxytocin (OT) is a peptide increasingly studied in relation to human social interactions, affiliation,
and clinical disorders. Studies are constrained by use of invasive blood draws and would benefit
from a reliable salivary OT assay. Our goals were to examine feasibility of salivary OT
measurement, compare salivary to plasma OT responses in 12 breast- and 8 formula-feeding
mothers, and assess the degree of correlation between plasma and salivary OT. Using a
commercial EIA kit, we measured OT in 5 saliva and 7 plasma samples in a protocol designed to
elicit changes in OT (Rest, Infant Interaction, Stress, Feeding). Breast-feeders had higher OT
levels than formula-feeders across all conditions in plasma (+36%) and saliva (+23%). OT levels
and ranges were similar in saliva and plasma, with slightly greater variance in saliva. Concurrently
sampled plasma and salivary OT were correlated at end of Baseline Rest (r = +.59, p = .022) and
Post-Stress Recovery (r = +.59, p = .025). These data suggest that salivary OT assay is feasible,
and will be of value where plasma samples are not possible. Validation with larger samples is
needed.
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Oxytocin (OT) is a mammalian neuropeptide that has increasingly garnered the interest of
researchers investigating biological correlates of human social interactions and relationships
(Baumgartner, Heinrichs, Vonlanthen, Fischbacher, & Fehr, 2008; Domes, Heinrichs,
Michel, Berger, & Herpertz, 2007; Grewen, Girdler, Amico, & Light, 2005; Holt-Lunstad,
Birmingham, & Light, 2008; Light, Grewen, & Amico, 2005; Neumann, 2008; Taylor et al.,
2000), as well as mechanisms involved in social deficits present in psychiatric disorders
including autism (Bartz & Hollander, 2008; Carter, 2007; Hollander et al., 2007; Jacob et
al., 2007; Meyer-Lindenberg, 2008; Posey, Erickson, & McDougle, 2008), schizophrenia
(Goldman, Marlow-O’Connor, Torres, & Carter, 2008; Keri, Kiss, & Kelemen, 2008),
depression (Cyranowski et al., 2008), and substance abuse (Light et al., 2000, 2004).
Understanding the physiology underlying normal and aberrant social interactions is
important because epidemiological evidence highlights a key role for social relationships in
health and disease, and suggests that more intimate, positive social affiliations may protect
and prolong good health (Berkman, 1995; Kiecolt-Glaser & Newton, 2001). Moreover,
promising new studies suggest that OT administration may attenuate some of the social
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deficits that characterize clinical disorders (Bartz & Hollander, 2008; Hollander et al., 2007;
Meyer-Lindenberg, 2008), and may increase prosocial behaviors in healthy volunteers
(Domes et al., 2007; Heinrichs & Domes, 2008).
OT has been hypothesized as a physiological mediator of an integrated ‘anti-stress’ response
attributable to social affiliation, with resulting long-term health benefits (Knox & Uvnas-
Moberg, 1998; Uvnas-Moberg, 1998a, 1998b). OT is produced primarily in the
hypothalamus, where it is released into the central and peripheral circulations to coordinate,
integrate, and modulate physiological, cognitive, and affective responses. Long known for
the role it plays in lactation, uterine contraction, and reproductive behaviors, OT has also
been linked to health-promoting cardiovascular (Diaz-Cabiale et al., 2000; Holst, Uvnas-
Moberg, & Petersson, 2002; Knox & Uvnas-Moberg, 1998; Petersson, Lundeberg, &
Uvnas-Moberg, 1999), metabolic (Bjorkstrand, Hulting, Meister, & Uvnas-Moberg, 1993;
Petersson, Hulting, Andersson, & Uvnas-Moberg, 1999; Uvnas-Moberg, 1994), analgesic
(Grewen, Light, Mechlin, & Girdler, 2008; Uvnas-Moberg, Bruzelius, Alster, & Lundeberg,
1993), anti-inflammatory (Petersson, Wiberg, Lundeberg, & Uvnas-Moberg, 2001) and
anxiolytic (Blume et al., 2008) effects.
Importantly, experimental evidence in animals and humans relate OT to social bonds and
interactions. Early animal studies, using more invasive and controlled methods, identify OT
release and receptor distribution in the brain as important for monogamous pair-bonding
(Williams, Carter, & Insel, 1992), social recognition, social memory (Ferguson, Aldag,
Insel, & Young, 2001; Ferguson et al., 2000) and response to positive pleasant social stimuli
(tactile, auditory, taste). Rodent, ungulate, and non-human primate models highlight the vital
role of OT in initiation of maternal behaviors (Carter, 1998; Insel, 2003) and early mother–
offspring interactions essential to offspring survival. In comparison, experimental studies in
humans are generally confined to less invasive peripheral plasma assays. Nevertheless, these
studies confirm that alterations in peripheral OT can be discerned in response to social
affiliative stimuli (Gonzaga, Turner, Keltner, Campos, & Altemus, 2006; Grewen et al,,
2005; Holt-Lunstad, et al., 2008; Light et al., 2005) and aspects of social relationships
(Taylor et al., 2006).
Measurable increases in plasma OT elicited by breast-feeding (Altemus, Deuster, Galliven,
Carter, & Gold, 1995; Altemus et al., 2001; Carter, Altemus, & Chrousos, 2001) make
breast- and formula-feeding mothers an attractive comparison for investigations of OT
correlates of psychosocial states and reactivity. Animal models support a role for OT in
reductions in stress reactivity in mothers during lactation, including reductions in
hypothalamic-pituitary-adrenal (HPA) (Windle et al., 1997a, 1997b) and fear responses to
stressors (Carter & Altemus, 1997). Whether lactation lowers anxiety and stress responsivity
in human mothers is still in question. Altemus et al. reported that lactation was associated
with reduced adrenocorticotropin hormone (ACTH), cortisol and glucose response to
physical exercise, decreased basal levels of norepinephrine, and reduced systolic blood
pressure (SBP) across all conditions in breast-feeding mothers (Altemus et al., 1995).
Notably, this same group found no difference between breast- and formula-feeders in OT
overall or in response to psychosocial stressors using the Trier Social Stress Test (TSST),
but did report greater vagal cardiac control in breast-feeding mothers (Altemus et al., 2001).
Consistent with these findings, our group reported no difference in blood pressure and heart
rate responses to experimental stressors (speech and cold pressor) but did see smaller and
less prolonged increases in vascular resistance (VR) responses in breast- compared with
formula-feeding mothers, and higher plasma OT was correlated with smaller VR reactivity.
In contrast to Altemus and colleagues, we reported a trend for greater OT concentrations
across the protocol (Grewen & Light, 2006), and greater likelihood of OT increases in
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response to infant contact in breast-feeding compared with formula-feeding mothers (Light
et al., 2000).
Because human plasma assays necessitate invasive methods, OT measures are often limited
by these technical requirements and are confined to clinical settings where blood sampling
can be conducted by personnel trained, at the very least, in phlebotomy methods. In
addition, plasma OT concentrations obtained by individual blood draws are likely to be
contaminated by a stress-induced OT increase in response to the stress of the needle stick.
Thus, an indwelling venous catheter and long habituation period prior to sampling are
necessary to measure true resting levels and to maximize changes elicited solely by
experimental manipulation. These difficulties make less invasive measurement of OT in
saliva an attractive alternative. Although the physiological role of oxytocin in saliva is not
entirely clear, measurement of OT, as with other commonly measured salivary endocrine
products including cortisol and alpha amylase, would be a valuable tool to noninvasively
assess changes in this neurohormone in clinical and nonclinical settings. Recent studies have
documented detectable concentrations of OT in saliva using an earlier enzyme immunoassay
(EIA) method without extraction (White-Traut et al., 2009), or using the sample method
described here (Holt-Lunstad, 2008). In each of these studies, saliva was collected in
subjects’ own homes and concurrent plasma was not sampled, so it is, at present, unclear
whether salivary OT will accurately reflect plasma concentrations.
Therefore, the three primary goals of this study were: 1) To examine the feasibility of non-
invasive measurement of OT in human subjects (mothers of infants) using a standard kit
assay with extraction; 2) To determine whether salivary OT would show increases and
decreases to a variety of behavioral conditions that parallel changes evident in plasma OT,
and would be equally good at differentiating responses from formula-feeding and breast-
feeding mothers; 3) To assess the degree of correlation between the two measures during a
limited number of conditions where both saliva and plasma samples were obtained
concurrently or within a short temporal window of each other.
Methods
Participants
Twenty healthy mothers (12 who reported breast-feeding for 90% or more of feedings, 8
who reported formula-feeding for 80% or more of feedings) were recruited from the
community during the perinatal period so that testing could be conducted within the window
of 1–3 months postpartum. Exclusion criteria included self-report of prescription drug use,
recent history of major depressive disorder and other psychological disorders, history of
chronic disease in mother or infant, multiple birth, low birth weight (less than 4.5 pounds),
gestational age less than 36 or greater than 42 weeks.
Protocol
All procedures were approved by the university institutional review board and all
participants underwent informed consent before testing. Mothers brought their infants to the
lab between 12:30–2:00 pm. Mothers were instrumented with cardiovascular electrodes for
measurement of blood pressure and cardiac function (results not reported), and a flexible
indwelling catheter (BD Saf-T-Intima, Becton Dickinson, Sandy, UT) was inserted into an
antecubital vein, with saline drip set at 0.25–1.00 drops per second to maintain lumen
patency. A habituation period of at least 30 min followed before start of testing. During this
time, subjects rested or sat quietly while blood pressure measurements were taken to
calibrate cardiovascular equipment and were allowed to feed their infants ad lib. During the
habituation period prior to testing, 7 women breast-fed and 2 women formula-fed their
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infants. The remaining 11 mothers declined to feed (5 breast, 6 formula), saying that their
infants had fed within the past hour (before leaving home).
The protocol consisted of the following events in fixed order: Baseline Rest (7 min),
Mother-Infant Video-Taped Interaction (5 min), Post-Interaction Rest (7 min), Speech Task
Stressor (8 min), Forehead Cold Pressor (2 min), Post-Stress Recovery (7 min), Infant
Feeding. Plasma and salivary OT samples were taken concurrently immediately following
baseline and post-interaction rests, and immediately following post-stress recovery. Plasma
was sampled after 10 min of feeding, and saliva was sampled immediately after feeding
(time varied between 10 and 19.5 min). Figure 1 shows the timing of the experimental
conditions and of plasma and salivary assays. Baseline Rest and Post-Task Recovery
Periods: Mothers were instructed to sit quietly and relax as much as possible without falling
asleep. A research assistant cared for the infant during this time but mothers were able to
have infants near and to be in control of infant care at all times in order to prevent stress-
induced OT responses during these periods. Mother-Infant Interaction (INXN): Infants were
seated in an infant seat directly in front of mother for the 5-min face-to-face mother-infant
interaction, while mother talked, touched, and played with her infant ad lib. Maternal
Speech Stress: Mothers were asked to give a short speech about a recent interpersonal event
that caused feelings of anger or stress. This included 2 min of silent preparation, 3 min of
active speaking (SPC), 3 min of passive listening to replay of audio-taped speech (REP).
Forehead Cold Pressor Stress (ICE): Aplastic bag of ice and water (~4°C) was held on the
forehead for 2 min. Infant Feeding (FEED): Mothers were instructed to feed infants for 10
min following the post-stress recovery period. There were no specific instructions save to
feed the infant for at least 10 min. If the infant finished feeding before that time, we
requested that mothers continue to hold their infants for the remainder of these 10 min. At
minute 10, plasma was sampled from the IV catheter which was obscured from mothers’
view by a curtain. Mothers were allowed to continue feeding after the 10 min if they desired.
Nineteen of 20 mothers fed for at least 10 min, while one mother fed for approximately 5
min. Mothers fed their infants during this feeding period (and during the habituation period)
consistent with their feeding status categorization (breast-feeding mothers breast-fed their
infants during the lab, formula-feeders fed with formula during the lab).
Measurements
Plasma was sampled for OT concentration at 7 time points: Baseline minute 7, Interaction
minute 5, Post-Interaction minute 7, Speech minute 1.5, Replay minute 1.5, Recovery
minute 7, Feeding minute 10. Saliva was sampled for OT assay at 5 time points: Baseline
minute 7, Post-Interaction minute 7, Ice minute 2, Recovery minute 7, Feed at completion
(ranging from minute 10–minute 20).
Sample collection—For plasma OT, venous blood samples were collected into pre-
chilled ethylenediaminetetraacetic acid (EDTA) tubes (1 mg/mL blood) and kept cold during
every step of processing. Because of the short half-life of OT peptide (1–6 min), the protease
inhibitor Aprotinin (500 KIU/mL blood) was added to each tube to attenuate metabolic
breakdown of peptide, as per strong recommendation by Assay Designs (Ann Arbor, MI) for
this EIA. Samples were immediately cold-centrifuged at 1600 × g for 15 min at 4°C. Plasma
was then pipetted into chilled CryoTubes and immediately frozen at −80°C until assay. For
salivary OT, unstimulated passive drool samples were collected. Upon arrival to the lab
visit, subjects were required to rinse their mouths thoroughly with water to remove any food
particles. To standardize collection for each sample, subjects were asked to reserve saliva in
their mouths without swallowing for 1 min, which was timed with a stopwatch. After 1 min
of saliva ‘saving,’ subjects used a straw to expectorate saliva into a pre-chilled 1.8 mL
CryoTube, which was suspended in a cup of ice throughout the collection process. At least 1
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mL of saliva was required for each sample. If subjects could not produce this amount after 1
min, samples were maintained in the ice cup while subjects collected saliva in their mouths
for an additional 1 min. Saliva produced after the 2nd minute was then added to the
CryoTube. CryoTubes were then immediately placed in a NUNC LabTop cooler
(Thermoscientific, Rochester, NY) to flash freeze at −20°C until protocol completion, when
all samples were transferred to −80°C until assay.
OT EIA—The method used to assay OT in saliva was similar to that specifically developed
and validated for salivary OT by Carter et al. (2007). However, it should be noted that the
current study used the latest Assay Designs OT EIA kit, which employs a different OT
antibody than the one marketed by the same company prior to 2006, and kit instructions
provided with this new antibody specify the need to perform an extraction step. Similar to
the method used by Carter and others, which concentrated the sample 4.0 times using a dry
down process (Bello, White-Traut, Schwertz, Pournajafi-Nazarloo, & Carter, 2008; Carter et
al., 2007; White-Traut et al., 2009), this required extraction step concentrates the sample 3.2
times. Notably, these differences in OT antibody and assay methods have resulted in marked
differences in absolute OT levels and sensitivity reported. Plasma OT values are higher (15–
300 pg/ml) in studies using the older antibody without extraction, compared with those
using this newer antibody (2–40 pg/mL) with the extraction step (Hoffman & Brownley,
2009; Holt-Lunstad et al., 2008). The kit states that the sensitivity limit of the assay with the
current OT antibody (without correcting for the concentration produced by the extraction
process) is 11.6 pg/mL, which is more than twice as high as with the different antibody
provided with the Assay Designs kit prior to 2006. The result of the extraction procedure
ensures that sample concentrations within the assay are above the assay sensitivity level and
are detectable on the linear portion of the standard curve.
In the current study, all samples were assayed in duplicate, and the method of extraction of
OT peptide was the same for both plasma and saliva samples, performed based on the
instructions accompanying the currently available EIA kit. The first step was to equilibrate a
strata-X 33 μm polymeric reversed phase SPE sorbent in a 96-well plate containing 60 mg
sorbent per well (Phenomenex, Torrance, CA) by adding 1 ml MeOH followed by 1 ml of
water. The second step was to acidify .8 ml of plasma or saliva with .4 ml of 1.5%
trifluoroacetic acid (TFA) and centrifuge at 6,000 × g for 20 min at 4°C. Third, this
supernatant was loaded onto the pre-treated strata-X plate, and the wells were slowly
washed with 1.5 ml of 0.1% TFA. Fourth, the peptide was eluted with 1 mL of 80%
acetonitrile, then the eluant was collected in a polystyrene tube and evaporated to dryness
under a nitrogen stream. Finally the residue was reconstituted in 250 ul of assay buffer. The
result of this extraction was to concentrate the sample 3.2 times, increasing precision and
reducing matrix interference. Extraction efficiencies were determined by spiking a known
amount of oxytocin into paired samples taken from homogenous pools of plasma and saliva
created and stored for this purpose. Recovery of these known amounts allowed
determination of OT extraction efficiencies of 96% for plasma and 93% for saliva.
OT levels in extracted plasma and saliva were then measured using the OT EIA, in which
the endogenous OT hormone competes for the OT antibody binding sites with added OT
linked to alkaline phosphatase. After the overnight incubation at 4°C, the excess reagents
were washed away and the bound OT phosphatase was incubated with substrate. After 1 h,
this enzyme reaction (which generates a yellow color) was stopped and the optical density
(OD) was read on a Sunrise plate reader (Tecan, Research Triangle Park, NC) at 405 nm.
The intensity of the color is inversely proportional to the concentration of OT in the sample.
The hormone content (in pg/ml) was determined by plotting the OD of each sample against a
standard curve. After correcting for concentration produced by extraction, the lower limit of
sensitivity was 2.0 pg/ml. The intra- and inter-assay variations for this assay, which were
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practically validated and determined using a set control sample with known OT
concentration on each plate and in each run, were 4.8% and 8%, respectively. Assay Designs
reports cross-reactivity for similar mammalian neuropeptides in sera at less than 0.001.
Statistical Analysis
In the current sample, 3% of saliva samples fell at or below the minimum detection level of
2 pg/mL (range 0.55–1.98 pg/ml), and were thus set at 2.0 pg/ml. Blood samples available
for assay decreased as the protocol progressed due to loss of IV access or hemolysis
(samples lost at baseline = 0, post-interaction = 2, replay = 3, recovery = 4) and our decision
to maintain IV access during feeding in a subsample (n = 10). OT concentration distributions
at each time point were not skewed or kurtotic and therefore are presented as untransformed
and unadjusted raw values.
We used Proc Mixed (SAS, Cary, NC) for repeated measures analyses to test differences in
group mean plasma and salivary OT levels between Breast and Formula-feeding mothers
across the protocol. Between-group t-tests were used to test differences in group mean OT
levels between Breast and Formula-feeding mothers at each measurement time point. Paired
t-tests were used to test within-subject changes in plasma and salivary OT levels across
consecutive experimental conditions. Pearson product moment correlations were used to test
the association of plasma and salivary OT levels assayed at each individual condition
(Baseline, Post-Interaction, Stress, Recovery, Feeding).
Results
Subject characteristics are displayed in Table 1. Mothers were healthy, with mean body
mass index (BMI) of 27.15 at time of testing between 30–96 days postpartum. Women
differed on self-reported race (10 African American (50%), 10 White (50%)), parity (12
multipara (60%), 8 primipara (40%)), and feeding method (12 Breast, 8 Formula). Infants
(10 male, 10 female) were healthy (mean birth weight: 7.04 pounds; mean gestational age:
39.35 weeks), unmedicated and free of acute illness or chronic disease at time of testing.
Plasma oxytocin concentrations varied across laboratory conditions
Plasma OT levels varied between subjects and within-subjects across experimental
conditions. Mean values, standard errors, and range are displayed in Table 2. Plasma OT
levels decreased significantly from 5-min mother-infant interaction to post-interaction rest
(Interaction: 4.86 ± 0.49, Post-Intx Rest: 4.16 ± 0.53 pg/mL; within-subjects paired t = 2.30,
p = .034), and increased significantly from post-interaction rest to minute 1.5 of speech task
(Rest: 4.16 ± 0.53, Speech: 4.82 ± 0.56 Q11 pg/mL; t = −2.67, p = .016). Mean plasma OT
level at baseline was significantly lower in the 6 formula-feeding mothers who did not feed
their infants during the habituation period compared with the 2 formula-feeding mothers
who did (2.93 ± 0.22 vs. 5.86 ± 1.31 pg/mL; p = .05). In the breast-feeding mothers,
however, baseline plasma OT did not differ between the 7 who did vs. the 5 who did not
feed their infants during habituation (5.79 ± 1.00 vs. 5.30+0.90 pg/mL, respectively).
Furthermore, no group differences between those mothers who fed vs. did not persisted
during the other experimental conditions.
Salivary oxytocin concentrations varied across laboratory conditions
In the current sample, 7% of the total 100 saliva samples were either of insufficient volume
or were too thick/viscous for reliable extraction and therefore could not be included in
analyses, and other samples (averaging 2.5 samples per time period) were missing due to
other methodological problems. Mean salivary OT concentrations, shown in Table 2, varied
across subjects and within subjects as a function of experimental condition. Significant
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within-subject increases in salivary OT from baseline to post-interaction rest were observed
(Base 4.67 ± 0.47, Post-Interaction: 5.62 ± 0.62 pg/mL, paired t = −2.69, p = .0225).
Salivary OT levels at any time during the protocol did not differ based on whether or not
mothers fed their infants during the habituation period.
Breast vs. Formula Feeding and Oxytocin
Mean plasma OT levels, depicted in Figure 2A, were higher across all conditions in breast-
feeding vs. formula-feeding mothers (significant main effect of Feeding group, Breast: 5.56
pg/mL, Formula: 4.10 pg/mL; F2,18 = 80.02, p < .0001).
Breast-feeding mothers also demonstrated greater mean salivary OT concentrations across
the protocol compared with formula-feeding mothers (significant main effect of feeding
group, Breast: 5.51 pg/mL, Formula: 4.48 pg/mL; F2,18 = 137.43, p < .0001), depicted in
Figure 2B.
Correlations of salivary and plasma oxytocin concentration
Plasma and salivary OT levels sampled immediately following resting Baseline were
positively correlated (r = +.59, p = .022) such that women with higher plasma OT also
demonstrated higher salivary OT. Figure 3 depicts this unadjusted relationship in data in 15
subjects from whom we obtained complete saliva and plasma samples for this period.
Similarly, a significant correlation of salivary and plasma OT collected at post-stress
recovery period was observed. Figure 4 depicts positively correlated plasma and saliva OT
concentrations immediately following the 7-min recovery rest period in 14 mothers with
available plasma and saliva data (r = +.59, p = .025).
Our study was not designed to assess correlations between plasma and saliva samples after
stressors or after feeding since sampling of saliva in those events occurred from 1–10 min
after the collection of plasma. At post-interaction rest, although samples were obtained in
close temporal association, the plasma and saliva OT levels were not correlated (r = −.04, p
= .88).
Discussion
The first goal of the present investigation was to examine the feasibility of measuring non-
invasive salivary OT in human subjects using a standard EIA kit assay with an extraction
step to concentrate the sample and reduce matrix interference. The goal was successfully
achieved since only 7% of the nearly 100 saliva samples were too thick and viscous or too
small in quantity to complete this assay effectively, and only 3% of the saliva samples from
20 mothers of infants yielded values below the threshold of detection.
The second goal of the study was to determine whether salivary OT levels can differentiate
responses between formula-feeding and breast-feeding mothers across a variety of
behavioral events in a comparable manner to plasma OT levels. This goal was partially
successful in that breast-feeding mothers demonstrated higher mean levels of both plasma
(+36%) and salivary (+23%) OT across all sampling times. This protocol successfully
elicited changes in maternal plasma and salivary OT levels in response to infant contact and
maternal stress. Both salivary and plasma OT levels increased when measured after infant
feeding compared with the previous post-stress resting recovery period; however, these
increases were not statistically significant. The small number of plasma OT samples taken
during this feeding session (n = 10) may have limited our power to see differences between
breast- and formula-feeding mothers at this time point. Across each individual time point in
the protocol, differences in mean OT levels between breast- and formula-feeding mothers
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tended to be greater, and the variances tended to be smaller for plasma OT compared with
salivary OT. This suggests that larger cell sizes may be necessary to detect differences with
the noninvasive salivary measure.
We also achieved partial success for the third goal of the study, which was to examine direct
correlations between plasma and salivary OT measures during three behavioral events (after
baseline rest, after recovery from mother-infant interaction, and after recovery from the two
stressors) where both saliva and plasma samples were obtained at nearly the same times. For
the baseline rest and the post-stressor recovery, the invasive and non-invasive OT measures
were closely correlated (both rs = +.59), while during recovery after interacting with their
infants, the two measures showed essentially no correlation. It is not clear why the two
measures failed to correlate for this post-interaction rest when breast- and formula-feeders
did differ in both plasma and saliva OT levels at this time point. However, plasma levels at
this time had fallen from the level seen immediately after the mother-infant interaction
ended, and it appears that the mean saliva levels after post-interaction recovery look more
like the plasma levels from right after the interaction ended. Thus, saliva levels may show a
greater lag time in terms of changes, and thus may more closely reflect plasma levels during
stable periods when the subjects are not showing marked increases or decreases.
Unlike Altemus et al. (2001), who did not find differences in levels of plasma OT in breast-
and formula-feeding mothers overall or in response to stressors, we did find significantly
higher OT levels in plasma across the protocol in breast-feeding mothers. Moreover, we also
found greater mean levels of salivary OT across the protocol in breast-feeding mothers.
However, although both plasma and salivary OT levels appeared to increase with infant
feeding, these increases were not statistically significant. This is not inconsistent with the
only previous investigation of salivary OT in breast-feeding mothers, which did not include
a formula-feeding comparison group, and simply documented that salivary OT levels
increased in a consistent manner during the 30-min period immediately before mothers
began to breast-feed their infants (White-Traut et al., 2009).
This study has several limitations. The sample size of 20 was quite modest, and replication
in a larger sample would be very appropriate, particularly given the variability associated
with salivary OT. Some variation in baseline OT levels and related responses may have
resulted because not all women elected to feed their infants during the habituation period
just prior to baseline. This may have influenced the baseline OT levels in formula-feeding
mothers, but did not appear to influence breast-feeding mothers, and did not affect OT
during later sampling points in either group. In future studies, we plan to standardize the
time since last feeding before testing. In addition, in this study breast-feeding infants had
greater contact with mothers’ skin and breast than formula-fed infants. In future studies, it
may be useful to standardize by having all mothers feed “skin-to-skin.” Finally, it would
have been much better if we had been able to obtain plasma and saliva samples within a few
minutes of each other under all testing conditions rather than just some of them.
Although this study showed that salivary OT will sometimes, but not always, demonstrate
similar responses to those seen in plasma OT, this does not lessen the potential value of the
less invasive measure. Under some circumstances, salivary OT may be the superior of the
two measures, or even the only possible measure to obtain. These circumstances include
testing of subjects who cannot or choose not to participate if their blood must be drawn
(such as children), and assessments during activities where needles are impractical, such as
at home and in other real life locations. As an example of the latter, Holt-Lunstad et al.
(2008) showed that salivary OT samples obtained at home were increased in married
couples when they had recently practiced warm listening touch and massage, and were
modestly correlated with plasma levels taken 1 week earlier in the clinic. In regard to the
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former, we are now continuing to use the mother-infant protocol described here, but are also
taking saliva samples for OT from the infants. We believe that the strengths and weaknesses
of this salivary sampling method are not different for OT than for other commonly measured
biomarkers such as salivary cortisol or alpha amylase.
In summary, this protocol successfully elicited changes in plasma and salivary OT
concentrations among 20 mothers in response to infant contact and stress. Levels and
changes in OT concentration differed across activities and between mothers using breast- vs.
formula-feeding methods. Similar means and ranges for OT values in saliva and plasma
were observed, and the two measures were correlated when obtained concurrently after
baseline rest and post-stress recovery. Feasibility of measuring salivary OT was a partial
success and warrants further investigation.
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Timing of protocol and oxytocin sampling. Base: Baseline rest; INXN: 5-min mother-infant
interaction; POST-INTXN: Post-interaction rest; SPC: Speech; REP: Speech replay; ICE: 2-
min forehead cold pressor; REC: Post-stress recovery; FEED: Infant feeding by breast or
formula.
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Mean plasma (A) and salivary (B) oxytocin concentrations (pg/mL) assayed at different time
points calculated for Breast and Formula-feeding mothers separately. Error bars depict
standard error of the mean. *p < .05.
GREWEN et al. Page 13














Pearson correlations between plasma and salivary oxytocin concentrations (pg/mL) sampled
at minute 7 of Resting Baseline.
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Pearson correlations between plasma and salivary oxytocin concentrations (pg/mL) sampled
at minute 7 of Resting Recovery following stressors.
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Table 1
Subject Characteristics
Variable Mean Std Err Range
Maternal age (years) 30.80 1.40 21.0–45.0
Body mass index (kg/m2) 27.15 1.10 18.6–39.1
Gestational age (weeks) 39.35 0.45 34.0–41.9
Birth weight (pounds) 7.04 0.32 4.9–10.0
Infant age at testing (days) 55.85 4.80 30.0–96.0
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